212 related articles for article (PubMed ID: 16979438)
1. Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT).
Wessels BW; Syh JH; Meredith RF
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S39-45. PubMed ID: 16979438
[TBL] [Abstract][Full Text] [Related]
2. Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
Shen S; Forero A; LoBuglio AF; Breitz H; Khazaeli MB; Fisher DR; Wang W; Meredith RF
J Nucl Med; 2005 Apr; 46(4):642-51. PubMed ID: 15809487
[TBL] [Abstract][Full Text] [Related]
3. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
[TBL] [Abstract][Full Text] [Related]
5. High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
Rajendran JG; Fisher DR; Gopal AK; Durack LD; Press OW; Eary JF
J Nucl Med; 2004 Jun; 45(6):1059-64. PubMed ID: 15181141
[TBL] [Abstract][Full Text] [Related]
6. Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy.
Hartmann Siantar CL; DeNardo GL; DeNardo SJ
J Nucl Med; 2003 Aug; 44(8):1322-9. PubMed ID: 12902424
[TBL] [Abstract][Full Text] [Related]
7. A radionuclide therapy treatment planning and dose estimation system.
Liu A; Williams LE; Lopatin G; Yamauchi DM; Wong JY; Raubitschek AA
J Nucl Med; 1999 Jul; 40(7):1151-3. PubMed ID: 10405136
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of internal emitters.
Sgouros G
J Nucl Med; 2005 Jan; 46 Suppl 1():18S-27S. PubMed ID: 15653648
[TBL] [Abstract][Full Text] [Related]
9. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
[TBL] [Abstract][Full Text] [Related]
10. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
[TBL] [Abstract][Full Text] [Related]
11. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
Chen Y; Geng J; Tian J; He Y; Chen S
Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
[No Abstract] [Full Text] [Related]
12. Three-dimensional dosimetry for radioimmunotherapy treatment planning.
Sgouros G; Chiu S; Pentlow KS; Brewster LJ; Kalaigian H; Baldwin B; Daghighian F; Graham MC; Larson SM; Mohan R
J Nucl Med; 1993 Sep; 34(9):1595-601. PubMed ID: 8394886
[TBL] [Abstract][Full Text] [Related]
13. Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
Pauwels S; Barone R; Walrand S; Borson-Chazot F; Valkema R; Kvols LK; Krenning EP; Jamar F
J Nucl Med; 2005 Jan; 46 Suppl 1():92S-8S. PubMed ID: 15653657
[TBL] [Abstract][Full Text] [Related]
14. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry in Peptide radionuclide receptor therapy: a review.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
[TBL] [Abstract][Full Text] [Related]
16. Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images.
Jarry G; Verhaegen F
Phys Med Biol; 2007 Apr; 52(8):2277-99. PubMed ID: 17404469
[TBL] [Abstract][Full Text] [Related]
17. Radiochromic film dosimetry of contrast-enhanced radiotherapy (CERT).
Morris KN; Weil MD; Malzbender R
Phys Med Biol; 2006 Nov; 51(22):5915-25. PubMed ID: 17068373
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted radionuclide therapy: trial design driven by patient dosimetry.
DeNardo SJ
J Nucl Med; 2000 Jan; 41(1):104-6. PubMed ID: 10647611
[No Abstract] [Full Text] [Related]
20. The importance of the accuracy of image registration of SPECT images for 3D targeted radionuclide therapy dosimetry.
Papavasileiou P; Divoli A; Hatziioannou K; Flux GD
Phys Med Biol; 2007 Dec; 52(24):N539-48. PubMed ID: 18065833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]